Technical Data
C9100-22F1
Cytomegalovirus Glycoprotein H, Late Neutralizing Antigen (CMV gH, HCMV, Human Herpes virus 5, HHV-5, HHV5), Concentrated
Description:
Cytomegalovirus gH is an important determinant of virus infectivity. The subunit structure associates with the gL-gH-gO complex. The interaction with gL is necessary for the correct processing and cell surface expression of gH.

Applications:
Suitable for use in ELISA, Immunofluorescence, Immunoprecipitation, Functional Assays and Immunohistochemistry. Other applications not tested.

Recommended Dilutions:
Immunohistochemistry: Frozen sections
Optimal dilutions to be determined by the researcher.

Recommended Secondary Antibodies:
I1904-06C: IgG, H&L (HRP) (X-Adsorbed) Pab Gt xMo
I1904-06H IgG, H&L (HRP) (X-Adsorbed) Pab Gt xMo
I1904-14C: IgG, Fc (HRP) Pab Gt xMo
I1904-19C: IgG, F(ab)2 (HRP) Pab Gt xMo

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG110B2667Affinity Purified
SizeStorageShippingSourceHost
200ug-20CBlue IceMouse
Concentration:
~4mg/ml
Immunogen:
Cytomegalovirus extracts
Purity:
Purified by Protein A affinity chromatography.
Form
Supplied as a liquid in PBS, sodium azide.
Specificity:
Recognizes Cytomegalovirus glycoprotein H (gH) late neutralizing antigen. Reacts with MRC-5 infected cells. Does not react with HSV, VZV, EBV or uninfected cells.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Cranage, M.P., et al., J. Virol. 62: 1416-1422 (1988). 2. Hamilton, A.A., et al., J. Infect. Dis. 176: 59-68 (1997).